uridine diphosphate has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agatemor, C; Buettner, M; Dammen-Brower, K; Fernandez-Gil, BI; Gowda, P; Khare, P; Le, A; Mathew, MP; Otamendi-Lopez, A; Quinoñes-Hinojosa, A; Saeui, CT; Shah, SR; Yang, S; Yarema, KJ; Zhang, C; Zhang, H | 1 |
| Cavazzoni, M; Orlati, S; Rugolo, M | 1 |
2 other study(ies) available for uridine diphosphate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Biosynthetic Pathways; Glucose; Hexosamines; Pancreatic Neoplasms; Uridine Diphosphate | 2023 |
Sphingosine-induced inhibition of capacitative calcium influx in CFPAC-1 cells.
Topics: Adenocarcinoma; Biological Transport; Calcium; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Humans; Manganese; Membrane Potentials; Mitochondria; Oligomycins; Pancreatic Ducts; Pancreatic Neoplasms; Propidium; Rhodamine 123; Rhodamines; Rotenone; Sphingosine; Thapsigargin; Tumor Cells, Cultured; Uncoupling Agents; Uridine Diphosphate | 1996 |